Brief: Docmorris Confirms EBITDA Breakeven In Course Of 2026 And Free Cash Flow Breakeven In Course Of 2027

DocMorris AG

20/01/2026 06:04

Jan 20 (Reuters) - DOCMORRIS AG DOCM.S:

FY EXTERNAL REVENUE CHF 1,185.8 MILLION

RX: UP 33.2 PER CENT FOR FULL YEAR; SEQUENTIAL GROWTH OF 6.1 PER CENT IN Q4

RX REVENUE UP 33.2% FOR FULL YEAR

EXTERNAL REVENUE UP 15.5% IN Q4 2025

CONFIRMS EBITDA BREAKEVEN IN COURSE OF 2026 AND FREE CASH FLOW BREAKEVEN IN COURSE OF 2027

NON-RX: UP 7.1 PER CENT FOR FULL YEAR; STRONG Q4 WITH 14.9 PER CENT GROWTH

SPECIFIES EBITDA FORECAST TO A RANGE OF MINUS CHF 48 TO MINUS CHF 52 MILLION FOR 2025

Source text: ID:nEQ2p2MfBa

Further company coverage: DOCM.S

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))